MBI for Psychological Distress, SI and NSSI Among Young Adults (NCT06263335) | Clinical Trial Compass
CompletedNot Applicable
MBI for Psychological Distress, SI and NSSI Among Young Adults
Pakistan60 participantsStarted 2022-02-28
Plain-language summary
Designed to measure the impact of Mindfulness Based Intervention on depression, anxiety, stress, psychological distress, Suicidal Ideation, Non-Suicidal Self Injury urge and Mindfulness in young adults. Those individuals who agree to participate in the trial and identified with high levels of psychological distress and Suicidal Ideation, randomly divided into interventional (n=30) and control (n=30) groups. The Mindfulness Based Stress Reduction intervention then administered to the interventional group for eight weeks and pre and post intervention assessment done for both the groups.
Who can participate
Age range
18 Years – 24 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants aged 18-24, of any gender, who consented to participate and could comprehend English (the language of the questionnaires).
* Selected respondents from the initial survey were included based on specific criteria:
* Willingness to continue participation.
* Unmarried status.
* Pursuing education (Bachelors, Masters, or Ph.D.) , Pakistan.
* Non-hosteller and unemployed.
* Residing with both parents.
* Affirmative response to screener questions about suicidal ideation (SI) and non-suicidal self-injury (NSSI).
* High scores on psychological distress and SI scales.
Exclusion Criteria:
* Participants failing to meet inclusion criteria or falling under the following categories were excluded:
* Non-students.
* History of present or past psychiatric illness, with recent medication or treatment within the past year.
* Presence of debilitating physical diseases or disabilities. Involvement in or history of substance use.
* Long-term medication for any condition, as these factors could impact study results.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.